|
US428051A
(en)
*
|
|
1890-05-13 |
|
Wood-working machine |
|
US575690A
(en)
*
|
|
1897-01-26 |
|
Match-safe |
|
US3568828A
(en)
|
1967-03-01 |
1971-03-09 |
Squibb & Sons Inc |
Modified sequential oral contraceptive
|
|
US4171358A
(en)
|
1974-04-19 |
1979-10-16 |
Eli Lilly And Company |
Novel contraceptive method
|
|
US4145416A
(en)
*
|
1976-06-23 |
1979-03-20 |
Schering, A.G. |
Novel agents and novel methods for treatment of climacteric disturbances
|
|
US4292315A
(en)
*
|
1977-12-30 |
1981-09-29 |
Nichols Vorys |
Follicular phase estrogen or progestin with physiologic estrogen/progestin luteal phase replacement drug delivery system
|
|
US4215691A
(en)
*
|
1978-10-11 |
1980-08-05 |
Alza Corporation |
Vaginal contraceptive system made from block copolymer
|
|
US4291014A
(en)
|
1979-01-11 |
1981-09-22 |
Key Pharmaceuticals, Inc. |
Polymeric diffusion matrix containing estradiol diacetate
|
|
US4438139A
(en)
*
|
1979-08-14 |
1984-03-20 |
Key Pharmaceuticals, Inc. |
Polymeric diffusion matrix containing estrogens
|
|
US4390531A
(en)
|
1981-08-10 |
1983-06-28 |
Syntex Pharmaceuticals International Ltd. |
Method of contraception using peak progestogen dosage
|
|
US4921843A
(en)
*
|
1988-10-20 |
1990-05-01 |
Pasquale Samuel A |
Contraception system and method
|
|
USRE35724E
(en)
*
|
1982-04-28 |
1998-02-03 |
Bio-Technology General Corp. |
Contraception system and method
|
|
US4826831A
(en)
*
|
1983-08-05 |
1989-05-02 |
Pre Jay Holdings Limited |
Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
|
|
US4628051A
(en)
|
1983-09-26 |
1986-12-09 |
Ortho Pharmaceutical Corporation |
Triphasic oral contraceptive
|
|
US4544554A
(en)
|
1983-09-26 |
1985-10-01 |
Ortho Pharmaceutical Corporation |
Triphasic oral contraceptive
|
|
US4530839A
(en)
|
1983-09-26 |
1985-07-23 |
Ortho Pharmaceutical Corporation |
Triphasic oral contraceptive
|
|
US4616006A
(en)
|
1983-09-26 |
1986-10-07 |
Ortho Pharmaceutical Corporation |
Triphasic oral contraceptive
|
|
US4534468A
(en)
|
1983-12-19 |
1985-08-13 |
Nuckols Walter S |
Calendar-oriented pill dispenser
|
|
US4736849A
(en)
|
1983-12-19 |
1988-04-12 |
Leonard Walter G |
Calendar-oriented pill dispenser
|
|
JPS60174716A
(ja)
|
1984-02-21 |
1985-09-09 |
Yamanouchi Pharmaceut Co Ltd |
パツチ剤
|
|
US4962098A
(en)
|
1987-06-15 |
1990-10-09 |
Warner-Lambert Company |
Graduated estrogen contraceptive
|
|
US5010070A
(en)
|
1987-06-15 |
1991-04-23 |
Warner-Lambert Company |
Graduated estrogen contraceptive
|
|
US4752478A
(en)
*
|
1984-12-17 |
1988-06-21 |
Merck & Co., Inc. |
Transdermal system for timolol
|
|
US5208225A
(en)
*
|
1986-02-27 |
1993-05-04 |
Warner-Lambert Company |
Compositions containing fixed combinations
|
|
US4762717A
(en)
|
1986-03-21 |
1988-08-09 |
The General Hospital Corporation |
Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive
|
|
DK174724B1
(da)
|
1986-07-15 |
2003-10-06 |
Wyeth Corp |
Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
|
|
US5256421A
(en)
*
|
1987-09-24 |
1993-10-26 |
Jencap Research Ltd. |
Hormone preparation and method
|
|
US5108995A
(en)
*
|
1987-09-24 |
1992-04-28 |
Jencap Research Ltd. |
Hormone preparation and method
|
|
US5276022A
(en)
|
1987-09-24 |
1994-01-04 |
Jencap Research Ltd. |
Hormone preparation and method
|
|
US4971998A
(en)
*
|
1987-10-22 |
1990-11-20 |
Massachusetts Institute Of Technology |
Methods for treating the premenstrual or late luteal phase syndrome
|
|
JP2938463B2
(ja)
*
|
1987-10-22 |
1999-08-23 |
マサチユセツツ・インスチチユート・オブ・テクノロジー |
月経前又は後期黄体期症候群の処置
|
|
US5043331A
(en)
*
|
1989-06-15 |
1991-08-27 |
Orion-Yhtyma Oy |
Treatment of postmenopausal disorders
|
|
US5098714A
(en)
|
1989-11-16 |
1992-03-24 |
Alza Corporation |
Osmotic, oral dosage form for fertility control
|
|
HU9301182D0
(en)
*
|
1990-10-25 |
1993-08-30 |
Schering Corp |
Method for producing fluoro-phenicole, its analogues and intermediary compounds
|
|
IE71203B1
(en)
|
1990-12-13 |
1997-02-12 |
Akzo Nv |
Low estrogen oral contraceptives
|
|
DE4104385C1
(cg-RX-API-DMAC10.html)
*
|
1991-02-09 |
1992-08-13 |
Marika Dr.Med. 6509 Framersheim De Ehrlich |
|
|
US5211952A
(en)
*
|
1991-04-12 |
1993-05-18 |
University Of Southern California |
Contraceptive methods and formulations for use therein
|
|
ZA924811B
(en)
*
|
1991-06-28 |
1993-12-29 |
Endorecherche Inc |
Controlled release systems and low dose androgens
|
|
MX9301121A
(es)
*
|
1992-03-02 |
1993-09-01 |
Schering Ag |
Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina.
|
|
DE4224534A1
(de)
|
1992-07-24 |
1994-01-27 |
Marika Dr Med Ehrlich |
Ovulationshemmendes Mittel zur hormonalen Kontrazeption
|
|
NL9301562A
(nl)
*
|
1993-09-09 |
1995-04-03 |
Saturnus Ag |
Preparaat voor substitutietherapie.
|
|
DE4344462C2
(de)
*
|
1993-12-22 |
1996-02-01 |
Schering Ag |
Zusammensetzung für die Empfängnisverhütung
|
|
DE4344405C2
(de)
*
|
1993-12-24 |
1995-12-07 |
Marika Dr Med Ehrlich |
Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption
|
|
DE4411585A1
(de)
*
|
1994-03-30 |
1995-10-05 |
Schering Ag |
Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
|
|
US5552394A
(en)
*
|
1994-07-22 |
1996-09-03 |
The Medical College Of Hampton Roads |
Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
|
|
DE4429374C1
(de)
*
|
1994-08-12 |
1996-02-01 |
Jenapharm Gmbh |
Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente
|
|
DE19513662A1
(de)
*
|
1995-04-08 |
1996-10-10 |
Schering Ag |
Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
|
|
DE19525017A1
(de)
|
1995-06-28 |
1997-01-02 |
Schering Ag |
Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
|
|
FR2737411B1
(fr)
|
1995-08-01 |
1997-10-17 |
Theramex |
Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
|
|
DE19531936A1
(de)
|
1995-08-17 |
1997-02-20 |
Schering Ag |
Kombinationspräparat zur Kontrazeption, Kits diese enthaltend und eine Methode diese verwendend
|
|
DE19540253C2
(de)
|
1995-10-28 |
1998-06-04 |
Jenapharm Gmbh |
Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
|
|
US5747480A
(en)
*
|
1996-05-08 |
1998-05-05 |
American Home Products Corporation |
Oral contraceptive
|
|
US6139873A
(en)
|
1996-07-10 |
2000-10-31 |
Cedars-Sinai Medical Center |
Combined pharmaceutical estrogen-androgen-progestin
|
|
KR20000029536A
(ko)
*
|
1996-07-26 |
2000-05-25 |
이곤 이 버그 |
2상피임방법및프로제스틴과에스트로젠과의배합물을포함하는킷
|
|
US6479475B1
(en)
|
1996-07-26 |
2002-11-12 |
Wyeth |
Oral contraceptive
|
|
AU3961697A
(en)
*
|
1996-07-26 |
1998-02-20 |
American Home Products Corporation |
Oral contraceptive
|
|
WO1998004246A2
(en)
|
1996-07-26 |
1998-02-05 |
American Home Prod |
Triphasic contraceptive method and kit comprising a combination of a progestin and estrogen
|
|
US5858405A
(en)
*
|
1996-07-26 |
1999-01-12 |
American Home Products Corporation |
Oral contraceptive
|
|
AU713016B2
(en)
*
|
1996-07-26 |
1999-11-18 |
Wyeth |
Oral contraceptive
|
|
WO1998004267A1
(en)
*
|
1996-07-26 |
1998-02-05 |
American Home Products Corporation |
Progestin/estrogen oral contraceptive
|
|
US6028064A
(en)
*
|
1996-09-13 |
2000-02-22 |
New Life Pharmaceuticals Inc. |
Prevention of ovarian cancer by administration of progestin products
|
|
US6765002B2
(en)
|
2000-03-21 |
2004-07-20 |
Gustavo Rodriguez |
Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
|
|
US6511970B1
(en)
*
|
1996-09-13 |
2003-01-28 |
New Life Pharmaceuticals Inc. |
Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
|
|
DE19705229C2
(de)
*
|
1997-02-12 |
1999-04-15 |
Hesch Rolf Dieter Prof Dr Med |
Verwendung von drei Hormonkomponenten zur hormonalen Kontrazeption zur Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
|
|
EP0968188A1
(de)
*
|
1997-03-20 |
2000-01-05 |
Basf Aktiengesellschaft |
Substituierte 2-benz(o)ylpyridin derivate, deren herstellung und deren verwendung als herbizide
|
|
US5898032A
(en)
*
|
1997-06-23 |
1999-04-27 |
Medical College Of Hampton Roads |
Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
|
|
US6251956B1
(en)
*
|
1998-08-20 |
2001-06-26 |
Ortho Pharmaceutical Corporation |
Combination progestin oral contraceptive regimen
|
|
DE19739916C2
(de)
*
|
1997-09-11 |
2001-09-13 |
Hesch Rolf Dieter |
Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
|
|
CA2301162A1
(en)
|
1997-09-12 |
1999-03-25 |
Michael Jay Gast |
Oral contraceptive preparation having a first phase comprising progestin/estrogen and a second phase comprising progestin
|
|
US6306914B1
(en)
*
|
1997-10-21 |
2001-10-23 |
Columbia Laboratories, Inc. |
Progestin therapy for maintaining amenorrhea
|
|
US6265393B1
(en)
*
|
1998-08-07 |
2001-07-24 |
Heinrichs William Leroy |
Prevention of endometriosis signs or symptons
|
|
US6214815B1
(en)
|
1998-12-23 |
2001-04-10 |
Ortho-Mcneil Pharmaceuticals, Inc. |
Triphasic oral contraceptive
|
|
US6787531B1
(en)
*
|
1999-08-31 |
2004-09-07 |
Schering Ag |
Pharmaceutical composition for use as a contraceptive
|
|
US20020132801A1
(en)
*
|
2001-01-11 |
2002-09-19 |
Schering Aktiengesellschaft |
Drospirenone for hormone replacement therapy
|
|
US20010044431A1
(en)
*
|
2000-03-21 |
2001-11-22 |
Rodriguez Gustavo C. |
Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
|
|
JP2004502729A
(ja)
*
|
2000-07-06 |
2004-01-29 |
ワイス |
Ｓｓｒｉおよびエストロゲン剤の組み合わせ
|
|
EP1390038A2
(en)
|
2001-05-16 |
2004-02-25 |
Endeavor Pharmaceuticals |
Treatment of conditions relating to hormone deficiencies by administration of progestins
|
|
US20030018018A1
(en)
*
|
2001-07-10 |
2003-01-23 |
Medical College Of Hampton Roads |
Ultra low dose oral contraceptives with sustained efficacy and induced amenorrhea
|
|
NZ591627A
(en)
|
2001-12-05 |
2012-09-28 |
Teva Womens Health Inc |
Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
|
|
ES2197801B1
(es)
*
|
2002-03-05 |
2005-03-16 |
Ferrer Internacional,S.A |
Procedimiento de obtencion de la 3-(2-(4-(6-fluoro-benzo(d)isoxazol-3-il) piperidin-1-il)-etil)-2-metil-6,7,8,9-tetrahidro-4h-pirido-(1,2-a ) pirimidin-4-ona.
|
|
US20030219471A1
(en)
|
2002-03-11 |
2003-11-27 |
Caubel Patrick Michel |
Extended cycle estrogen and sulfatase inhibiting progestogen contraceptive regimens
|
|
AU2003220171A1
(en)
*
|
2002-03-11 |
2003-09-29 |
Janssen Pharmaceutica N.V. |
Continuous sulfatase inhibiting progestogen hormone replacement therapy
|
|
US20040142914A1
(en)
*
|
2002-03-11 |
2004-07-22 |
Friedman Andrew Joseph |
Extended transdermal contraceptive regimens
|
|
EP1494679A4
(en)
*
|
2002-04-03 |
2009-10-28 |
Barr Lab Inc |
STEP-BY-STEP ESTROGENTHERAPY
|
|
US7772219B2
(en)
|
2003-05-02 |
2010-08-10 |
Teva Women's Health, Inc. |
Methods of hormonal treatment utilizing extended cycle contraceptive regimens
|
|
US20040251301A1
(en)
|
2003-05-05 |
2004-12-16 |
Niemann Amy C. |
Device for calculating anticipated days for menstruation
|
|
US20040222123A1
(en)
|
2003-05-06 |
2004-11-11 |
Barr Laboratories, Inc. |
Kit for pharmaceuticals
|
|
CA2771944A1
(en)
*
|
2003-07-16 |
2005-01-27 |
Teva Women's Health, Inc. |
Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
|
|
WO2005023657A2
(en)
|
2003-09-04 |
2005-03-17 |
Pharmadesign Inc. |
Case with pill receiving sleeves for storing and dispensing pills
|
|
AU2004277998A1
(en)
|
2003-10-01 |
2005-04-14 |
Janssen Pharmaceutica N.V. |
Extended triphasic contraceptive regimens
|
|
US20070111975A1
(en)
|
2004-10-07 |
2007-05-17 |
Duramed Pharmaceuticals, Inc. |
Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
|
|
TW200626161A
(en)
*
|
2004-10-07 |
2006-08-01 |
Duramed Pharmaceuticals Inc |
Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
|
|
CA2640432A1
(en)
*
|
2006-01-27 |
2007-08-09 |
Duramed Pharmaceuticals, Inc. |
Regimens for treatment of conditions related to estrogen deficiency
|